Dr. Joyce Lee

Position:Patent Scientist
Email:joyce.lee@spruson.com

Academic Qualifications

QualificationInstitution Year of Completion
PhD in Medical ScienceGriffith University, Australia2019
BSc in Biomedical ScienceUniversity of Dundee, United Kingdom2013

Industry Experience

PositionOrganisation/InstitutionDate of Tenure
Research FellowProgram of Emerging Infectious Diseases, Duke-NUS Medical School, SingaporeAugust 2020 – September 2022

Selected Publications – industry/IP specific

Publications
Yousefi M, Lee WS, Chan WOY, et al. (2023) Betacoronaviruses SARS-CoV-2 and HCoV-OC43 infections in IGROV-1 cell line require aryl hydrocarbon receptor. Emerg Microbes Infect. 12(2):2256416.
Yousefi M, Lee WS, Yan B, et al. (2022) TMEM41B and VMP1 modulate cellular lipid and energy metabolism for facilitating dengue virus infection. PLoS Pathog. 18(8):e1010763.
Lee WS, Yousefi M, Yan B, Yong CL, Ooi YS (2021). Know your enemy and know yourself - the case of SARS-CoV-2 host factors. Curr Opin Virol. 50:159-170.
Chen W, Foo SS, Hong E., Wu C, Lee WS, et al. (2021). Zika virus NS3 protease induces bone morphogenetic protein-dependent brain calcification in human fetuses. Nature microbiology. 6(4), 455–466.
Lee WS, Webster JA, et al. (2019). Mosquito antiviral defense mechanisms: a delicate balance between innate immunity and persistent viral infection. Parasit Vectors. 12(1):165.
Foo SS, Chen W, Chan Y, Lee WS, et al. (2018). Biomarkers and immunoprofiles associated with fetal abnormalities of ZIKV-positive pregnancies. JCI insight. 3(21), e124152.
Lim EXY, Supramaniam A, Lui H, Coles P, Lee WS, et al (2018). Chondrocytes Contribute to Alphaviral Disease Pathogenesis as a Source of Virus Replication and Soluble Factor Production. Viruses. 10(2), 86.
Lim EXY, Lee WS, et al (2018). Mosquitoes as Suitable Vectors for Alphaviruses. Viruses. 10(2), 84.
Lee WS, et al (2017). Alphaviral targeted antivirals: evaluating the old, planning the future. Future Virology. 12:2, 49-54
Ong HB, Lee WS, et al (2015). Homoserine and quorum-sensing acyl homoserine lactones as alternative sources of threonine: a potential role for homoserine kinase in insect-stage Trypanosoma brucei. Mol Microbiol. 95(1):143-156.
Experience and Technical Background

Experienced in the following areas of patent practice:

  • Prosecution of patents
  • Drafting of patents

 

Primary patent practice areas by technology:

  • Virology
  • Cloning and Gene editing
  • Molecular Biology
  • Cell Biology
  • Vaccines and Antibodies

Research/industry background:

A. General technical areas:

  • Molecular virology
  • CRISPR/Cas genome editing technology
  • Glycobiology
  • Molecular Biology
  • Vaccines and Antibodies

B. Honours research:

  • Characterisation of a putative homoserine kinase in Trypanosoma brucei, which is an attractive druggable target to treat Human African Trypanosomiasis.

C. PhD research:

  • Discovery of host factors involved in viral entry and replication of mosquito-transmitted viruses including Zika virus, Ross River virus, and dengue virus.

D. Industry experience:

  • Discovery of host factors co-opted by human respiratory viruses for replication and pathogenesis using one of the most advanced function genomic approaches, CRISPR/Cas genome editing technology.

Would you like to join the Spruson & Ferguson team?


Work For Us

Contact our Expert Team

Contact Us